On 17 June, the WHO released its latest update on the Monkeypox outbreak situation. The sharp growth of confirmed cases during the last two months indicates increasing uncertainty of the endemic progress. Between 1 January and 15 June 2022, a cumulative total of 2103 laboratory confirmed cases, one probable case, and one death were laboratory-confirmed had reported to WHO from 42 countries in five WHO Regions. The majority of cases (98%) have been reported since May 2022. Most cases are recognized and reported from European countries, followed by the American region.
Today, we Bioperfectus are proud to announce that STC-96A and STC-96A PLUS Real-Time PCR Systems have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing. With FDA registration, Bioperfectus Real-Time PCR Systems obtained access to PCR laboratories in the US. With stable performance and user-friendly design, STC-96A and STC-96A Plus will be great helpers for molecular laboratories to identify the virus and bacterial.
Countries worldwide celebrate World Blood Donor Day (WBDD) every year. The event serves to raise awareness of the need for safe blood and blood products and to thank voluntary, unpaid blood donors for their life-saving gifts of blood.
The Automated Nucleic Acid Extraction Workstation SAW-96 (referred to as "SAW-96" below) produced by Jiangsu Bioperfectus Technologies Co., Ltd. is an in-vitro diagnostic medical device that integrates cutting-edge mechanical, electronic, and software technologies.
Monkeypox, a rare zoonotic infectious disease caused by the monkeypox virus, is mainly spread in endemic countries in Africa. However, things seem to become different in recent days. After 20 days since the first case outside endemic countries was spotted in the UK on 2022 May 7, a cumulative total of 257 laboratory-confirmed cases and around 120 suspected cases in non-endemic countries from 23 WHO member states have been reported, according to the lasted update by WHO. Meanwhile, WHO also expects that there will be more cases identified as the surveillance expands in more and more regions.
Recently, our esteemed customer, the No.(1) Defence Services General Hospital (1000-Bedded) in Yangon, Myanmar, published their research on the Breakthrough infections due to SARS-CoV-2 Wild type, the Delta variant and the Omicron variant in early fourth wave of epidemics in Myanmar. The paper was published in February 2022 on the International Journal of Medical Science and Clinical Research Studies (Impact Factor: 5.276).
We Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) solemnly announce that we have received CE mark approval for Monkeypox Virus Real Time PCR Kit.
The recent ongoing monkeypox virus cases outbreak in nonendemic countries caused a series of concerns in public health. As a molecular diagnostic supplier, we are launching Monekypox Virus Real Time PCR Kit as a detection tool to combat the potential spread among people.
On 15 April 2022, the World Health Organization (WHO) published an alert on severe acute hepatitis cases of unknown origin in children in the United Kingdom. Since then, there have been continuing additional reports of cases.
After SSNP-2000B got the IF award, its application in nucleic acid detection grew with stronger momentum. Conquering the judges with exclusive features, SSNP-2000B also obtained more and more recognition from clinical operators.
